Market Intelligence
Market Sizing & TAM Studies
Accurate TAM calculations depend on representative sampling, not just large n. We design quota structures against verified firmographic segments—so your sizing model reflects the actual market, not the panel composition.
- — Firmographic quota management by revenue band and headcount
- — Geographic stratification down to metro or DMA level
- — Incidence rate transparency for modeling inputs
Product Research
Conjoint & Pricing Studies
Conjoint utilities are particularly sensitive to response quality contamination. Random or disengaged responding corrupts part-worth estimates in ways that don't show up in standard quality diagnostics. Our behavioral scoring applies tighter thresholds for analytically intensive study types.
- — Tightened timing thresholds for choice task completion
- — Internal consistency checks on attribute trade-offs
- — Verified buyer authority for pricing research
Regulatory & Clinical
Regulatory Submission Research
Studies that inform FDA submissions, NICE evaluations, or EMA filings operate under a fundamentally different evidence standard. We provide full methodology documentation in formats aligned with regulatory submission requirements, and our healthcare panels use license verification as a base requirement.
- — License board verification for clinical respondents
- — IRB/HRA-compatible documentation package
- — Full audit trail with sampling rationale
Tracking
Brand & Awareness Tracking
Longitudinal studies have a specific problem: over-surveying the same respondents changes their behavior. Our frequency caps and respondent rotation protocols are designed specifically for ongoing tracking programs—maintaining fresh samples without compromising target profile verification.
- — Respondent rotation with profile-verified refreshes
- — 90-day frequency cap with monitoring alerts
- — Wave-over-wave consistency reporting